相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts
Sonya C. Tate et al.
CLINICAL CANCER RESEARCH (2014)
LY2835219, a selective inhibitor of CDK4 and CDK6, inhibits growth in preclinical models of human cancer.
Jack A. Dempsey et al.
CANCER RESEARCH (2013)
PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma
Kelly L. Barton et al.
PLOS ONE (2013)
Cyclin-dependent kinase inhibitors move into Phase III
Malini Guha
NATURE REVIEWS DRUG DISCOVERY (2012)
A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells
Lars Anders et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Array-Based Comparative Genomic Hybridization Identifies CDK4 and FOXM1 Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor
Jinsheng Yu et al.
CLINICAL CANCER RESEARCH (2011)
Brain metastases as preventive and therapeutic targets
Patricia S. Steeg et al.
NATURE REVIEWS CANCER (2011)
A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma
Marta Puyol et al.
CANCER CELL (2010)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
Targeting the cancer kinome through polypharmacology
Zachary A. Knight et al.
NATURE REVIEWS CANCER (2010)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis
Elise M. Pelletier et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia
Lisheng Wang et al.
BLOOD (2007)
RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer
Gerold Bepler et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Constitutively activated FLT3 phosphorylates BAD partially through Pim-1
Kyu-Tae Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Cyclin-dependent kinase pathways as targets for cancer treatment
GI Shapiro
JOURNAL OF CLINICAL ONCOLOGY (2006)
Location, location, location: The role of cyclin D1 nuclear localization in cancer
AB Gladden et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Pathogenesis of mantle-cell lymphoma:: All oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways
V Fernàdez et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival
KT Kim et al.
BLOOD (2005)
An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines
JD Davidson et al.
CANCER RESEARCH (2004)
The genetics of malignant melanoma: Lessons from mouse and man
L Chin
NATURE REVIEWS CANCER (2003)
Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV
S de Vos et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2003)
Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma
Y Zhu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Retinoblastoma tumor suppressor targets dNTP metabolism to regulate DNA replication
SP Angus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control
T Oelgeschläger
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
To cycle or not to cycle: A critical decision in cancer
M Malumbres et al.
NATURE REVIEWS CANCER (2001)
Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis
S Ishida et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer
AB Sandler et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
